Results 11 to 20 of about 38,634 (255)

The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling [version 1; peer review: 2 approved]

open access: yesGates Open Research, 2019
The Global Programme to Eliminate Lymphatic Filariasis was launched in 2000 to eliminate lymphatic filariasis (LF) as a public health problem by 1) interrupting transmission through mass drug administration (MDA) and 2) offering basic care to those ...
NTD Modelling Consortium Lymphatic Filariasis Group
doaj   +2 more sources

Filariasis

open access: yesRevista de Ciencias Médicas de Pinar del Río, 2015
Introducción: la filariasis es una parasitosis importada producida por nemátodos (gusanos redondos) hemáticos de la familia Filariidae. Existen alrededor de 200 tipos de filarias parásitas pero solo unas pocas parasitan al hombre.
Nayaris Gómez Martínez   +4 more
doaj   +3 more sources

FILARIASIS [PDF]

open access: yesAnnals of the New York Academy of Sciences, 1948
SUMMARYFilariasis is a disease in humans which affects many thousands of individuals in the tropical and subtropical areas of the world. There is no doubt that the economy and welfare of many lands are seriously affected by these infections in spite of the fact that they are associated with very low mortality rates.
G, MELTON, E, MONTUSCHI
openaire   +4 more sources

Wolbachia depletion blocks transmission of lymphatic filariasis by preventing chitinase-dependent parasite exsheathment

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2022
Significance Lymphatic filariasis caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori affects 51 million people, leading to severe physical and mental disabilities.
Shannon Quek   +12 more
semanticscholar   +1 more source

Lymphatic filariasis in Asia: a systematic review and meta-analysis

open access: yesParasitology Research, 2021
Lymphatic filariasis (LF) is an important neglected parasitic disease according to the World Health Organization. In this study, we aimed to determine the prevalence of human LF in Asia using a systematic review and meta-analysis approach.
Negar Bizhani   +4 more
semanticscholar   +1 more source

Lymphatic Filariasis: A Systematic Review on Morbidity and Its Repercussions in Countries in the Americas

open access: yesInternational Journal of Environmental Research and Public Health, 2021
The Global Program to Eliminate Lymphatic Filariasis (GPELF) is a program that aims to eliminate lymphatic filariasis by 2030. The GPELF strategy is based on interrupting transmission using mass drug administration (MDA) and, in parallel, managing ...
Z. Medeiros   +6 more
semanticscholar   +1 more source

Successful management of poisoning with ivermectin (Mectizan) in the Obala health district (Centre Region, Cameroon): a case report

open access: yesJournal of Medical Case Reports, 2023
Background Ivermectin (Mectizan) is an anthelmintic drug that plays a major role in the fight against two major filarial diseases, onchocerciasis and lymphatic filariasis.
Cyrille Donfo-Azafack   +4 more
doaj   +1 more source

Human filariasis—contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model

open access: yesParasitology Research, 2021
Filariae are vector-borne parasitic nematodes that are endemic worldwide, in tropical and subtropical regions. Important human filariae spp. include Onchocerca volvulus, Wuchereria bancrofti and Brugia spp., and Loa loa and Mansonella spp.
Frederic Risch   +3 more
semanticscholar   +1 more source

High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination

open access: yesInfectious Diseases of Poverty, 2022
Background The current mainstay for control/elimination of onchocerciasis and soil-transmitted helminthiasis (STH) relies on ivermectin- and mebendazole/albendazole-based preventive chemotherapies.
Hugues C. Nana-Djeunga   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy